ArticleOncology and therapy2026

Real-World Patient Characteristics, Treatment Patterns, and Clinical Outcomes in Patients with Relapsed or Refractory Multiple Myeloma Receiving Teclistamab: A Panel Chart Review Study.

Binod Dhakal et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.